VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AZTA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AZTAAzenta, Inc.
$25.67$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAZTAFinancials

Azenta, Inc. (AZTA) Financials

30Y historyFree accessUpdated daily

Revenue growth remains muted at 1.0% year-over-year, while structural inefficiencies have pushed operating margins into negative territory at -10.6% as of 2026Q2.

AZTA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97Sep'96
Sales/Revenue596.57M593.82M573.45M665.07M555.5M513.7M388.54M780.85M631.56M527.5M560.32M552.71M482.85M422.44M519.45M688.11M592.97M218.71M526.37M743.26M607.49M463.75M535.05M343.61M304.25M381.72M321.1M103.9M99.9M86.4M90.4M
Revenue Growth %1.85%3.55%-13.78%19.73%8.14%32.21%-50.24%23.64%19.73%-5.86%1.38%14.47%14.3%-18.68%-24.51%16.04%171.13%-58.45%-29.18%22.35%31%-13.33%55.72%12.94%-20.29%18.88%209.05%4%15.63%-4.42%97.81%
Cost of Goods Sold330.8M323.54M318.83M431.82M324.88M299.19M243.66M488.82M404.82M341.84M373.04M371.3M315.11M288.22M348.17M465.08M426.68M224.7M399.54M523.66M420.84M303.61M335.92M239.94M221.21M229.33M159.66M47.8M64.3M53.6M49.5M
COGS % of Revenue-54.48%55.6%64.93%58.48%58.24%62.71%62.6%64.1%64.8%66.58%67.18%65.26%68.23%67.03%67.59%71.96%102.74%75.91%70.46%69.28%65.47%62.78%69.83%72.71%60.08%49.72%46.01%64.36%62.04%54.76%
Gross Profit265.77M270.28M254.62M233.26M230.62M214.51M144.87M292.02M226.74M185.66M187.28M181.41M167.74M134.22M171.29M223.02M166.29M-6M126.83M219.59M186.65M160.14M199.13M103.67M83.04M152.38M161.44M56.1M35.6M32.8M40.9M
Gross Margin %44.55%45.52%44.4%35.07%41.52%41.76%37.29%37.4%35.9%35.2%33.42%32.82%34.74%31.77%32.97%32.41%28.04%-2.74%24.09%29.54%30.72%34.53%37.22%30.17%27.29%39.92%50.28%53.99%35.64%37.96%45.24%
Gross Profit Growth %-6.15%9.16%1.14%7.51%48.07%-50.39%28.79%22.13%-0.87%3.24%8.15%24.97%-21.64%-23.2%34.11%2873.43%-104.73%-42.24%17.65%16.56%-19.58%92.09%24.83%-45.5%-5.61%187.78%57.58%8.54%-19.8%108.67%
Operating Expenses281.42M281.55M284.6M315.45M254.64M210.91M172.4M236.89M192.32M167.5M167.8M159.1M163.75M142.68M149.79M142.39M116.76M122.84M153.44M166.94M162.86M147.91M152.9M215.81M675.83M186.97M144.02M64.4M57.3M31.8M27.9M
OpEx % of Revenue-47.41%49.63%47.43%45.84%41.06%44.37%30.34%30.45%31.75%29.95%28.79%33.91%33.77%28.84%20.69%19.69%56.17%29.15%22.46%26.81%31.89%28.58%62.81%222.13%48.98%44.85%61.98%57.36%36.81%30.86%
Selling, General & Admin247.85M251.16M253.08M281.5M227.1M188.5M156.28M180.52M145.38M127.62M116.26M106.87M111.1M96.47M102.32M102.54M85.6M91.23M110.52M115.22M117.22M84.8M87.07M98.31M101.2M95.92M70.86M31.6M26.5M12.8M12.4M
SG&A % of Revenue-42.3%44.13%42.33%40.88%36.69%40.22%23.12%23.02%24.19%20.75%19.34%23.01%22.84%19.7%14.9%14.44%41.71%21%15.5%19.3%18.29%16.27%28.61%33.26%25.13%22.07%30.41%26.53%14.81%13.72%
Research & Development33.56M30.39M31.52M33.96M27.54M22.41M16.12M56.37M46.94M39.88M51.54M52.23M52.65M46.21M47.46M39.85M31.16M31.61M42.92M51.72M45.64M63.12M65.82M72.89M75.06M60.87M42.95M22.4M22.7M14.2M12.4M
R&D % of Revenue-5.12%5.5%5.11%4.96%4.36%4.15%7.22%7.43%7.56%9.2%9.45%10.9%10.94%9.14%5.79%5.26%14.45%8.15%6.96%7.51%13.61%12.3%21.21%24.67%15.95%13.38%21.56%22.72%16.44%13.72%
Other Operating Expenses0000000000000000000000044.6M499.57M30.19M30.21M10.4M8.1M4.8M3.1M
Operating Income-15.64M-11.27M-29.98M-82.2M-24.02M3.6M-27.53M55.13M34.42M18.16M19.48M22.3M3.99M-8.46M21.5M80.63M49.54M-128.83M-26.61M52.66M23.79M12.22M46.23M-158.4M-627.82M-43.9M17.42M-8.3M-21.7M1M13M
Operating Margin %-2.62%-1.9%-5.23%-12.36%-4.32%0.7%-7.08%7.06%5.45%3.44%3.48%4.04%0.83%-2%4.14%11.72%8.35%-58.91%-5.06%7.08%3.92%2.64%8.64%-46.1%-206.35%-11.5%5.43%-7.99%-21.72%1.16%14.38%
Operating Income Growth %-62.42%63.53%-242.16%-768.05%113.06%-149.93%60.16%89.52%-6.75%-12.67%459.25%147.15%-139.34%-73.34%62.78%138.45%-384.12%-150.54%121.39%94.58%-73.56%129.19%74.77%-1329.98%-351.99%309.92%61.75%-2270%-92.31%96.97%
EBITDA41.14M49.94M60.76M3.39M29.68M60.47M37.97M109.58M71.12M45.36M47.52M47.46M27.29M15.7M43.12M97.88M68.04M-102.98M7.93M85.46M55.45M28.57M63.78M-126.59M-589.79M1.35M47.64M2.1M-13.6M5.8M16.1M
EBITDA Margin %6.9%8.41%10.6%0.51%5.34%11.77%9.77%14.03%11.26%8.6%8.48%8.59%5.65%3.72%8.3%14.22%11.47%-47.09%1.51%11.5%9.13%6.16%11.92%-36.84%-193.85%0.35%14.84%2.02%-13.61%6.71%17.81%
EBITDA Growth %-28.64%-17.81%1694.54%-88.59%-50.92%59.25%-65.35%54.07%56.79%-4.55%0.13%73.93%73.84%-63.6%-55.95%43.87%166.07%-1399.24%-90.73%54.12%94.05%-55.19%150.38%78.54%-43755.66%-97.16%2168.38%115.44%-334.48%-63.98%106.41%
D&A (Non-Cash Add-back)56.78M61.21M90.74M85.58M53.7M56.87M65.5M54.45M36.7M27.2M28.05M25.16M23.3M24.16M21.62M17.25M18.5M25.86M34.54M32.8M31.66M16.35M17.54M31.81M38.03M45.26M30.21M10.4M8.1M4.8M3.1M
EBIT-7.61M-7.14M-19.13M-30.43M-5.35M-46.93M-37.35M31.69M29.99M14.93M4.11M18.21M-1.49M-14.54M11.42M127.58M56.06M-226.92M-235.75M56.22M33.45M6.72M44.95M-109.04M-592.79M-34.59M20.08M-9.1M-25.5M-3M13.5M
Net Interest Income19.48M18.78M33.18M43.73M15.7M-1.41M-2.1M-20.8M-7.64M56K295K504K748K1.03M1.2M1.09M1.04M2.27M7M11.31M4.33M-185K-4.51M-5.97M-450K000000
Interest Income19.48M18.78M33.18M43.73M20.29M632K849K1.45M1.88M464K452K899K950K1.03M1.21M1.15M1.12M2.72M7.4M11.9M13.71M9.28M4.98M4.07M9.84M000000
Interest Expense00004.59M2.04M2.94M22.25M9.52M408K157K395K202K2K14K65K80K454K407K583K9.38M9.47M9.49M10.04M10.29M000000
Other Income/Expense-134.03M4.13M10.86M51.77M14.09M-52.56M-12.77M-45.69M-13.96M-4.1M-13.14M-4.65M-4.45M-3.64M-7.95M49.73M6.74M-98.3M-208.83M4M1.27M-14.97M-10.78M-22.24M680K7.8M8.36M-2.5M-2.5M-700K200K
Pretax Income-149.67M-7.14M-19.13M-30.43M-9.94M-48.97M-40.29M9.44M20.47M14.07M6.33M17.65M-460K-12.1M13.55M130.36M56.28M-227.13M-235.44M56.66M25.05M-2.75M35.46M-180.85M-627.41M-36.1M25.51M-8.9M-22.7M400K13M
Pretax Margin %-25.09%-1.2%-3.34%-4.58%-1.79%-9.53%-10.37%1.21%3.24%2.67%1.13%3.19%-0.1%-2.86%2.61%18.94%9.49%-103.85%-44.73%7.62%4.12%-0.59%6.63%-52.63%-206.21%-9.46%7.94%-8.57%-22.72%0.46%14.38%
Income Tax-39.79M-31.6M5.24M-17.55M1.35M-20.1M-13.93M-111K-47.25M3.38M75.81M3.43M-1.98M-4.99M-123.28M1.95M-2.75M643K1.23M2.29M3.37M5.2M8.05M4.91M92.82M-6.44M12.75M-1M-4.3M-400K4.5M
Effective Tax Rate %26.58%442.41%-27.4%57.67%-13.59%41.05%34.57%-1.18%-230.88%24.03%1196.87%19.43%430.43%41.2%-909.63%1.5%-4.88%-0.28%-0.52%4.04%13.46%-189.17%22.71%-2.71%-14.79%17.84%50%11.24%18.94%-100%34.62%
Net Income-178.16M-55.76M-164.9M-14.26M-428.96M110.75M64.85M28.82M116.58M62.61M-69.48M14.22M4.46M-2.21M136.79M128.35M58.98M-227.86M-236.63M67.57M25.93M-8.1M27.2M-185.76M-719.95M-29.66M12.75M-7.9M-18.4M800K8.5M
Net Margin %-29.86%-9.39%-28.76%-2.14%-77.22%21.56%16.69%3.69%18.46%11.87%-12.4%2.57%0.92%-0.52%26.33%18.65%9.95%-104.18%-44.95%9.09%4.27%-1.75%5.08%-54.06%-236.63%-7.77%3.97%-7.6%-18.42%0.93%9.4%
Net Income Growth %-175.49%66.18%-1056.6%96.68%-487.33%70.77%125.06%-75.28%86.19%190.12%-588.55%218.78%301.4%-101.62%6.57%117.61%125.89%3.71%-450.17%160.6%420.28%-129.77%114.64%74.2%-2327.36%-332.57%261.43%57.07%-2400%-90.59%84.78%
Net Income (Continuing)-109.88M24.46M-24.37M-12.88M-11.29M-28.87M-26.36M9.55M67.72M10.69M-69.48M14.22M1.52M-7.11M136.84M128.4M59.02M-227.77M-236.68M54.37M21.68M-7.96M27.41M-182.66M-719.95M-29.66M15.11M-9.8M-23.3M-4.2M8.6M
Discontinued Operations-3.78M-80.22M-140.53M-1.37M-417.68M139.62M91.22M19.26M48.75M51.92M003.1M4.96M0000013.27M3.58M0000000000
Minority Interest0000000000000700K635K589K537K494K409K463K394K1.06M918K707K493K762K1.19M1.5M000
EPS (Diluted)-3.87-1.22-3.09-0.22-0.15-0.390.880.141.640.89-1.010.210.46-0.032.082.010.93-3.62-3.662.040.36-0.220.41-5.05-27.90-1.650.88-0.71-1.78-0.660.94
EPS Growth %-184.89%60.52%-1304.55%-46.67%61.54%-144.32%528.57%-91.46%84.27%188.12%-580.95%-54.35%1469.05%-101.62%3.48%116.13%125.69%1.09%-279.41%466.67%263.64%-153.66%108.12%81.9%-1590.91%-287.5%223.94%60.11%-169.7%-170.21%30.56%
EPS (Basic)--1.22-3.09-0.22-0.15-0.390.880.141.650.90-1.020.210.47-0.032.102.020.94-3.62-3.662.060.36-0.220.41-5.05-27.90-1.650.96-0.71-1.78-0.661.06
Diluted Shares Outstanding46.06M45.9M53.17M66.25M74.9M74.45M73.85M72.39M70.94M70.48M68.51M68.55M67.64M65.91M65.72M65M64.17M62.91M64.54M74.07M72.53M44.92M43.47M36.77M25.81M18.02M17.19M11.19M10.34M7.88M8.62M
Basic Shares Outstanding46.06M45.74M53.17M66.25M74.9M74.23M73.56M71.99M70.49M69.58M68.37M67.41M66.65M65.26M65.13M64.55M63.78M62.91M64.54M73.49M72.32M44.92M43.01M36.77M25.81M18.02M15.66M11.19M10.34M7.88M7.64M
Dividend Payout Ratio-----26.84%45.51%100.27%24.26%44.61%-189.8%512.78%-15.32%4.04%--------------1.18%

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Geopolitical and R&D cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Stagnant Revenue Amidst Cyclical Headwinds

According to recent quarterly filings, Azenta's revenue growth has remained largely stagnant, with the most recent period showing a marginal 1.0% year-over-year increase to $144.8 million, reflecting the ongoing difficulty in scaling top-line performance within a cautious biotechnology capital expenditure environment.

The revenue trajectory appears to be struggling to find momentum, as the company oscillates between low single-digit growth and periodic contractions. This suggests that the core business is highly sensitive to the R&D spending cycles of its pharmaceutical clients, which may be deferring large-scale automation investments.

Structural Margin Compression Remains Persistent

As reported in financial statements, Azenta's gross margin has hovered around 42.8% to 45.5% over the last ten quarters, indicating that the company's premium positioning is currently insufficient to overcome the high fixed-cost burden inherent in its global laboratory and biorepository infrastructure.

The inability to consistently expand gross margins suggests that the company may lack the necessary pricing power to offset rising operational costs. Investors should monitor whether the 'Ascend' transformation program can successfully drive efficiency, or if the current margin profile is structurally capped by the nature of its service-heavy business model.

Operating Leverage Remains Elusive

Based on Azenta's reported figures, operating income has frequently dipped into negative territory, including a $15.3 million loss in 2026Q2, which highlights a lack of meaningful operating leverage as SG&A expenses continue to consume a significant portion of the company's gross profit.

The persistent operating losses suggest that the company's cost structure is not scaling efficiently with revenue. This indicates that management's efforts to streamline operations have yet to yield the desired bottom-line impact, leaving the company vulnerable to further earnings volatility.

Earnings Volatility Masked by Non-Operating Items

Analysis of the income statement reveals that Azenta's net income is subject to extreme fluctuations, such as the $160.8 million loss reported in 2026Q2, which appears to be driven by non-operating items rather than core operational performance, complicating the assessment of true earnings power.

The significant disparity between operating results and net income suggests that investors should be cautious when evaluating EPS, as restructuring charges and other non-recurring items frequently distort the bottom line. The reliance on non-operating factors to explain net income swings warrants further investigation into the company's underlying profitability.

Structural Risks to Long-Term Profitability

Short-sellers may focus on the fact that Azenta has struggled to maintain positive operating margins, with the most recent data showing a -10.6% operating margin, suggesting that the company's business model may be fundamentally challenged by its high-cost laboratory footprint and reliance on volatile biotech spending.

The counter-narrative suggests that the 'annuity-like' storage business may not be enough to offset the capital-intensive nature of the products segment. If the company fails to demonstrate a clear path to sustained profitability, the market may continue to discount the stock as a low-margin hardware provider rather than a high-value infrastructure play.

AZTA — Frequently Asked Questions

Quick answers to the most common questions about buying AZTA stock.

What was Azenta, Inc.'s (AZTA) revenue in 2025?

For fiscal year 2025, Azenta, Inc. (AZTA) reported total revenue of $593.8M. This represents a 556.9% increase compared to $90.4M in 1996.

Is Azenta, Inc. (AZTA) profitable?

Azenta, Inc. (AZTA) reported a net loss of $55.8M for the fiscal year ending 2025.

What is Azenta, Inc.'s operating profit margin?

Azenta, Inc. (AZTA) reported an operating income of $-11.3M, resulting in an operating profit margin of -1.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Azenta, Inc.'s gross profit and gross margin?

Azenta, Inc. (AZTA) generated $270.3M in gross profit for the year, representing a gross profit margin of 45.5%. This demonstrates the company's core pricing power and production efficiency.